Literature DB >> 9469470

Increased mortality, blunted production of nitric oxide, and increased production of TNF-alpha in endotoxemic TGF-beta1 transgenic mice.

Y Vodovotz1, J B Kopp, H Takeguchi, S Shrivastav, D Coffin, M S Lucia, J B Mitchell, R Webber, J Letterio, D Wink, A B Roberts.   

Abstract

The expression of the inducible isoform of nitric oxide synthase (NOS2, iNOS) is increased in patients undergoing sepsis as well as in animal models in which septic shock is induced by injection of bacterial lipopolysaccharide (LPS). Transforming growth factor-beta1 (TGF-beta1) potently suppresses NO production both in vitro and in vivo. After intraperitoneal injection of LPS, mice over-expressing a cDNA coding for active TGF-beta1 in the liver (Alb/ TGF-beta1) exhibited reduced serum levels of the NO reaction products NO2(-) + NO3(-) compared with controls. Paradoxically, while endotoxemic Alb/ TGF-beta1 mice expressed much less NOS2 protein in peritoneal exudate cells than did endotoxemic wild-type mice, Alb/TGF-beta1 mice expressed more NOS2 mRNA and protein in both liver and kidney. Alb/ TGF-beta1 mice treated with LPS had eightfold higher serum tumor necrosis factor alpha (TNF-alpha) levels and experienced increased mortality compared with wild-type mice, which was associated with renal insufficiency. These results suggest that renal dysfunction, decreased production of NO, and/or increased production of TNF-alpha are associated with increased mortality of endotoxemic Alb/TGF-beta1 mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469470     DOI: 10.1002/jlb.63.1.31

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage.

Authors:  Eray Kara; Ahmet Var; Seda Vatansever; Serap Cilaker; Yavuz Kaya; Teoman Coşkun
Journal:  Curr Ther Res Clin Exp       Date:  2004-05

2.  SMAD4 is required for development of maximal endotoxin tolerance.

Authors:  Hongjie Pan; Enyu Ding; Mai Hu; Anand S Lagoo; Michael B Datto; Sandhya A Lagoo-Deenadayalan
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

Review 3.  The role of transforming growth factor β1 in the regulation of blood pressure.

Authors:  Kota Matsuki; Catherine K Hathaway; Marlon G Lawrence; Oliver Smithies; Masao Kakoki
Journal:  Curr Hypertens Rev       Date:  2014

Review 4.  Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.

Authors:  Yoram Vodovotz; Ruben Zamora; Matthew J Lieber; Shirley Luckhart
Journal:  Curr Mol Med       Date:  2004-11       Impact factor: 2.222

5.  Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1β, TNF-α, IL-6, and HMGB1 expression.

Authors:  André L F Sampaio; Jesmond Dalli; Vincenzo Brancaleone; Fulvio D'Acquisto; Mauro Perretti; Carmen Wheatley
Journal:  Mediators Inflamm       Date:  2013-05-28       Impact factor: 4.711

6.  The return of the Scarlet Pimpernel: cobalamin in inflammation II - cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS.

Authors:  Carmen Wheatley
Journal:  J Nutr Environ Med       Date:  2007-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.